Myriad Genetics MYGN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $151.3M+35.2% | $111.9M-20.6% | $140.9M+112% | $66.4M-74.3% | ||
| $115.3M-4.9% | $121.2M+6.0% | $114.3M+12.5% | $101.6M+11.3% | ||
| $30.6M+11.3% | $27.5M+25.0% | $22M+9.5% | $20.1M+31.4% | ||
| $332.6M+11.6% | $298M-5.0% | $313.6M+14.2% | $274.6M-43.4% | ||
| $114M-2.9% | $117.4M-1.3% | $119M+42.7% | $83.4M+91.7% | ||
| $51.6M-82.0% | $286.3M-0.4% | $287.4M+0.2% | $286.8M+19.9% | ||
| $153.4M-41.5% | $262.4M-24.9% | $349.5M-8.0% | $379.7M-6.0% | ||
| $706.6M-31.2% | $1.03B-10.4% | $1.15B-4.4% | $1.2B-9.2% | ||
| $30M-7.1% | $32.3M+25.2% | $25.8M-10.4% | $28.8M-2.7% | ||
| $133.8M-18.5% | $164.1M+5.3% | $155.9M+13.6% | $137.2M-32.8% | ||
| $119.9M+203% | $39.6M+2.9% | $38.5M— | $0— | ||
| $338.6M+3.7% | $326.5M-10.1% | $363.3M+16.1% | $312.9M-11.3% | ||
| 900K0.0% | 900K0.0% | 900K+12.5% | 800K0.0% | ||
| -$1.12B-48.3% | -$756.8M-20.2% | -$629.5M-71.9% | -$366.2M-44.1% | ||
| $368M-47.5% | $701.1M-10.5% | $783.2M-11.6% | $885.8M-8.5% | ||
| $706.6M-31.2% | $1.03B-10.4% | $1.15B-4.4% | $1.2B-9.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Myriad Genetics's total assets?
- Myriad Genetics (MYGN) holds $673.7M in total assets, down 33.0% year over year.
- How much debt does Myriad Genetics have?
- Myriad Genetics carries $211.5M in total debt against $337.4M of shareholders' equity, a debt-to-equity ratio of 0.63.
- How much cash does Myriad Genetics have?
- Myriad Genetics holds $126.0M in cash and equivalents.
- Can Myriad Genetics cover its short-term obligations?
- Its current ratio is 2.40 — current assets exceed current liabilities.
- Where does Myriad Genetics's balance sheet data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
